Abortion industry praises pharmacy for slashing price of morning after pill for Christmas party season

28 November 2019

Copy of Add a little bit of body text 43

UK abortion giant, British Pregnancy Advisory Service (BPAS), has praised Dr Fox online pharmacy for slashing the price of the morning after pill to £3 ahead of the Christmas party season and encouraging women to ‘stock up.’ SPUC’s Director of Research, Dr Anthony McCarthy said: “It should worry us that Dr Fox is being praised by the abortion industry for pushing cut-price drugs.”

The price slash which has arrived just ahead of the Christmas party season and which could encourage women to engage more in “risky” sexual activity, has been applauded by BPAS representative, Clare Murphy. Murphy states that the drug is “extremely safe” and that it can be used “as often as needed”.

The morning after pill is typically purchased at a price of £26 and dispensed following a consultation with a pharmacist. BPAS is calling for the drug to be sold in “supermarkets and vending machines, like condoms.” Dr Fox ships the drugs for a “standby” supply at home after the woman has filled out an online questionnaire.

Dangers of the drug

SPUC Director of Campaigns, Antonia Tully, said: "The sweeping claim by Clare Murphy of BPAS that the morning after pill is “extremely” safe is misleading. Levonorgestral, the generic name of the drug, is a powerful hormonal drug; powerful enough, according to medical literature, to be able to alter the lining of the womb to prevent implantation if conception occurs. This drug may cause a very early abortion: a new human life may be lost.

“Furthermore, medical information states that it should not be taken repeatedly. Encouraging women to stockpile the morning after pill could put their health at risk.”

The morning after pill can act as a form of early abortion by making the lining of the womb hostile to newly conceived human embryos and killing them. Women are often not informed that the morning after pill is a potential abortifacient.

A survey showed that in 2010, approximately six out of 10 British women had used the drug. A review of 23 studies on the use of the morning after pill concluded that “no study has shown that increased access to this method reduces unintended pregnancy or abortion rates.”

A 2015 study also suggests that access to the morning-after pill can also lead to higher rates of sexually transmitted infection.